title: Bortezomib: Potential Key Role in the Treatment of Multiple Myeloma-Related Acquired Hemophilia A.
authors.affiliation: Serviço de Hematologia Clínica, Centro Hospitalar de São João, Porto, Portugal.
authors.forename: Gil de Paiva
authors.initials: GP
authors.lastname: Brás
authors.affiliation: Serviço de Hematologia Clínica, Centro Hospitalar de São João, Porto, Portugal.
authors.forename: Ricardo Jorge Sancio Moreira
authors.initials: RJ
authors.lastname: Pinto
authors.affiliation: Serviço de Imunohemoterapia, Centro Hospitalar de São João, Porto, Portugal.
authors.forename: Maria Manuela Marques Cardoso
authors.initials: MM
authors.lastname: Carvalho
authors.affiliation: Serviço de Imunohemoterapia, Centro Hospitalar de São João, Porto, Portugal.
authors.forename: Susana Patrícia Beleza Nobre
authors.initials: SP
authors.lastname: Fernandes
authors.affiliation: Serviço de Hematologia Clínica, Centro Hospitalar de São João, Porto, Portugal.
authors.forename: Joaquim José Aguiar
authors.initials: JJ
authors.lastname: Andrade
authors.affiliation: Serviço de Hematologia Clínica, Centro Hospitalar de São João, Porto, Portugal.
authors.forename: José Eduardo Torres Eckenroth
authors.initials: JE
authors.lastname: Guimarães
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000069286:Bortezomib / Q000008:administration & dosage / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D000069286:Bortezomib